OSE Immunotherapeutics Appoints Alexis Vandier as Chief Executive Officer
August 3, 2022
OSE Immunotherapeutics NANTES, France, July 13, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the appointment of Alexis Vandier as Chief Executive Officer, effective immediately. Alexis Vandier brings an impressive track record of successes in Pharma across a range of international roles and therapeutic areas, including oncology.
Read the source article at Yahoo Canada Sports
2022-07-13 16:00:00
